DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arranon (Nelarabine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Arranon (Nelarabine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Arranon side effects in female

Reported by a physician from Japan on 2012-07-25

Patient: female, weighing 39.6 kg (87.1 pounds)

Reactions: Hepatic Function Abnormal, Hyperphosphataemia, Hyperkalaemia, Hypotension, Ventricular Arrhythmia, Acidosis, Coagulation Time Abnormal

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Arranon
    Dosage: 650mgm2 per day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-04-23
    End date: 2011-04-27

Dexamethasone
    Dosage: 6.6mg per day
    Start date: 2011-04-28
    End date: 2011-04-29

Dexamethasone
    Dosage: 6.6mg per day
    Indication: Neoplasm Malignant
    Start date: 2011-04-20
    End date: 2011-04-20

Dexamethasone
    Dosage: 6.6mg per day
    Start date: 2011-05-06
    End date: 2011-05-06

Dexamethasone
    Dosage: 13.2mg per day
    Start date: 2011-04-21
    End date: 2011-04-27

Other drugs received by patient: Decadron; Hydrocortisone Sodium Succinate; Sodium Bicarbonate; Pentazocine Lactate; Granisetron; Ifosfamide; Allopurinol; Fentanyl; Bosmin; Mucosta; Solita-T NO 3; Furosemide; Atarax; Potassium Chloride; Ketoprofen; Daunorubicin HCL; Fildesin; Methotrexate; Decadron; Polaramine; Diamox; Loxoprofen; Leunase; Furosemide; Seishoku; Lorcam; Platelets; Ketalar



Possible Arranon side effects in female

Reported by a physician from Japan on 2012-07-10

Patient: female, weighing 39.6 kg (87.1 pounds)

Reactions: Hepatic Function Abnormal, Hyperkalaemia, Hyperphosphataemia, Hypotension, Ventricular Arrhythmia, Acidosis, Coagulation Time Abnormal

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Arranon
    Dosage: 650mgm2 per day
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2011-04-23
    End date: 2011-04-27

Dexamethasone
    Dosage: 13.2mg per day
    Start date: 2011-04-21
    End date: 2011-04-27

Dexamethasone
    Dosage: 6.6mg per day
    Start date: 2011-04-28
    End date: 2011-04-29

Dexamethasone
    Dosage: 6.6mg per day
    Start date: 2011-05-06
    End date: 2011-05-06

Dexamethasone
    Dosage: 6.6mg per day
    Indication: Neoplasm Malignant
    Start date: 2011-04-20
    End date: 2011-04-20

Other drugs received by patient: Leunase; Decadron; Solita-T; Daunorubicin HCL; Methotrexate; Mucosta; Decadron; Hydrocortisone Sodium Succinate; Furosemide; Fentanyl; Ketoprofen; Fildesin; Sodium Bicarbonate; Potassium Chloride; Pentazocine Lactate; Furosemide; Polaramine; Atarax; Bosmin; Lorcam; Ifosfamide; Allopurinol; Granisetron; Diamox; Seishoku; Platelets; Ketalar; Loxoprofen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012